Jun 13, 2023 / 04:20PM GMT
Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research Analyst
All right. Welcome, everybody. Good morning. I'm Matt Sykes, the Life Sciences Tools and Diagnostics analyst at Goldman Sachs. And I have a pleasure to welcome Thierry Bernard, the CEO of QIAGEN here today. Thierry, thank you very much for being here.
Thierry Bernard - Qiagen N.V. - CEO, MD & Member of Management Board
Thanks for having us.
Questions and Answers:
Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research AnalystAnd maybe why don't we just start out, let you kind of set the stage a little bit. Last quarter, you once again exceeded expectations for net sales growth and EPS in the quarter. Maybe walk us through some of the key accomplishments and any expectations you have over the course of this year?
Thierry Bernard - Qiagen N.V. - CEO, MD & Member of Management Board
So first of all, good morning, everybody, and thanks for your